B Leeneman
Impact in
-
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 9
- Cutaneous Melanoma Detection and Management 9
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 1
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Co-authors
- M Franken (10 shared papers)Carin A. Uyl‐de Groot (11 shared papers)John B.A.G. Haanen (6 shared papers)Michel W.J.M. Wouters (7 shared papers)Hedwig M. Blommestein (7 shared papers)Alexander C. J. van Akkooi (3 shared papers)Hans M. Westgeest (2 shared papers)Pieter van Baal (3 shared papers)
- Journals
- European Journal of Cancer (5 papers)Value in Health (5 papers)ESMO Open (1 paper)Cancers (1 paper)Melanoma Research (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
B Leeneman
15 papers receiving 160 citations
Peers
Comparison fields: 5 of 52
- Oncology 76
- Dermatology 7
- Cancer Research 9
- Small Animals 4
- Immunology 8
Countries citing papers authored by B Leeneman
This map shows the geographic impact of B Leeneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Leeneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Leeneman more than expected).
Fields of papers citing papers by B Leeneman
This network shows the impact of papers produced by B Leeneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Leeneman. The network helps show where B Leeneman may publish in the future.
Co-authors
The 25 scholars most cited alongside B Leeneman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 33 | |
| 2 | 2019 | 31 | |
| 3 | 2021 | 28 | |
| 4 | 2021 | 22 | |
| 5 | 2019 | 21 | |
| 6 | 2020 | 12 | |
| 7 | 2015 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2018 | 2 | |
| 10 | 2015 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2025 | 0 |
About B Leeneman
B Leeneman is a scholar working on Oncology, Economics and Econometrics, Molecular Biology, Computational Theory and Mathematics and Toxicology, having authored 16 papers that have together received 163 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (9 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Computational Drug Discovery Methods (2 papers), Melanoma and MAPK Pathways (2 papers), CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), vaccines and immunoinformatics approaches (1 paper) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Oncology (76 citations), Dermatology (7 citations), Cancer Research (9 citations), Small Animals (4 citations) and Immunology (8 citations). B Leeneman has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include M Franken, Carin A. Uyl‐de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Hedwig M. Blommestein, Alexander C. J. van Akkooi, Hans M. Westgeest, Pieter van Baal, K. Schreuder and Marieke W.J. Louwman. Their work appears in journals such as European Journal of Cancer, Value in Health, ESMO Open, Cancers and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.